"India's cancer strategy must prioritise early detection over late-stage treatment"
Multi-Cancer Early Detection (MCED)
blood-based test detecting biological signals from multiple cancers in a single sample
Catastrophic health expenditure
out-of-pocket spending exceeding a threshold share of household income, pushing families into poverty
India's public health architecture has historically been skewed toward curative care — building tertiary hospitals, training specialists, and expanding treatment capacity — while preventive and promotive healthcare received comparatively less investment. The National Health Policy 2017 marked a formal acknowledgement of this imbalance, explicitly prioritising preventive, promotive, and rehabilitative care alongside curative services. The policy also recognised that India's disease burden was shifting from communicable to non-communicable diseases (NCDs), with cancer, cardiovascular disease, and diabetes collectively accounting for a growing share of morbidity and mortality.
Within the NCD landscape, cancer occupies a particularly urgent position. India's cancer control framework has evolved through successive National Cancer Control Programmes, culminating in the integration of cancer screening into the Ayushman Bharat – Health and Wellness Centres (AB-HWCs) model, which mandates population-based screening for oral, breast, and cervical cancers at the primary care level. The Universal Immunisation Programme (UIP), operationalised through the National Health Mission (NHM), has extended to include HPV vaccination for adolescent girls — a preventive intervention targeting cervical cancer specifically. Despite these structural advances, the fundamental challenge of late-stage presentation persists across virtually all cancer types.
The core problem in India's cancer landscape is a systemic diagnostic delay. Over 70% of cancer patients present at advanced stages, when five-year survival rates collapse and treatment costs escalate sharply. This is not merely a clinical failure — it is a governance and public health design failure. The consequences are measurable: more than three-quarters of cancer-affected households face catastrophic healthcare expenditure, directly linking late diagnosis to household poverty and financial vulnerability.
Comparative survival data illustrates the stakes. Five-year survival for lung cancer in India stands at approximately 4%, against nearly 33% in Japan — a gap that reflects not treatment quality differences alone, but the stage at which patients enter the system. Japan's organised screening infrastructure ensures earlier detection; India's does not yet replicate this at scale.
The article identifies three structural levers for change. …
Consider the following statements:
Statement-I: India's public sector health care system largely focuses on curative care with limited preventive, promotive and rehabilitative care.
Statement-II: Under India's decentralized approach to health care delivery, the States are primarily responsible for organizing health services.
Which one of the following is correct in respect of the above statements?
With reference to Ayushman Bharat Digital Mission, consider the following statements:
1.Private and public hospitals must adopt it.
2.As it aims to achieve universal health coverage, every citizen of India should be part of it ultimately.
3.It has seamless portability across the country.
Which of the statements given above is/are correct?
With reference to cancer burden in India, consider the following statements:
1.More than 70% of cancer patients in India present at advanced stages of the disease.
2.The five-year survival rate for lung cancer in India is comparable to that in high-income countries.
3.Over three-quarters of cancer-affected households in India face catastrophic healthcare expenditure.
Which of the statements given above is/are correct?
Which of the following best describes Multi-Cancer Early Detection (MCED) tests?
Consider the following statements regarding India's cancer control framework:
1.Ayushman Bharat – Health and Wellness Centres mandate population-based screening for oral, breast, and cervical cancers.
2.The National Health Policy 2017 prioritised curative care over preventive and promotive healthcare.
3.NITI Aayog is supporting the development of an imaging biobank comprising cancer patient profiles to accelerate AI tool development.
Which of the statements given above is/are correct?
Assertion (A): India's investment in advanced tertiary cancer treatment centres has not proportionately improved cancer survival outcomes.
Reason (R): The majority of Indian cancer patients present at advanced stages, limiting the effectiveness of even sophisticated treatment interventions.
Which one of the following is correct?
Want the full note, Prelims Facts & MCQ answers?
Create a free account — takes less than a minute.
Create free account